Metrics to compare | OIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOILPeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.9x | −1.5x | −0.2x | |
PEG Ratio | −2.33 | −0.04 | 0.00 | |
Price / Book | 6.6x | 3.6x | 2.6x | |
Price / LTM Sales | 34.7x | 2.4x | 2.6x | |
Upside (Analyst Target) | - | 121.8% | 76.9% | |
Fair Value Upside | Unlock | 20.8% | 14.9% | Unlock |
Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.